Insider Transactions in Q2 2022 at Pacira Bio Sciences, Inc. (PCRX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2022
|
Charles Anthony Laranjeira Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+12.56%
|
$228,000
$38.35 P/Share
|
|
Jun 08
2022
|
Laura Brege Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,160
+10.26%
|
-
|
|
Jun 08
2022
|
Christopher Christie Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,160
+24.97%
|
-
|
|
Jun 08
2022
|
Yvonne Greenstreet Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,160
+8.05%
|
-
|
|
Jun 08
2022
|
Paul J Hastings Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,160
+13.07%
|
-
|
|
Jun 08
2022
|
Mark A. Kronenfeld Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,160
+6.09%
|
-
|
|
Jun 08
2022
|
Gary W Pace Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,160
+0.84%
|
-
|
|
Jun 08
2022
|
Mark Froimson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,160
+16.05%
|
-
|
|
Jun 08
2022
|
Daryl Gaugler Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,900
+22.98%
|
-
|
|
Jun 08
2022
|
Dennis Mc Loughlin Chief Customer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,950
+16.66%
|
-
|
|
Jun 08
2022
|
Anthony Molloy Chief Lgl & Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,950
+28.49%
|
-
|
|
Jun 08
2022
|
Charles Anthony Laranjeira Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,900
+21.69%
|
-
|
|
Jun 08
2022
|
Charles Anthony Laranjeira Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
4,937
-4.23%
|
$296,220
$60.57 P/Share
|
|
Jun 08
2022
|
Max Reinhardt President, Rest of World |
BUY
Grant, award, or other acquisition
|
Direct |
7,950
+19.78%
|
-
|
|
Jun 08
2022
|
Charles A. Reinhart Iii Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,950
+17.99%
|
-
|
|
Jun 08
2022
|
Lauren Bullaro Riker Senior Vice President, Finance |
BUY
Grant, award, or other acquisition
|
Direct |
5,850
+22.76%
|
-
|
|
Jun 08
2022
|
Jonathan Slonin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,900
+20.63%
|
-
|
|
Jun 08
2022
|
Kristen Marie Williams Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,900
+29.6%
|
-
|
|
Jun 08
2022
|
Roy Winston Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,900
+18.01%
|
-
|
|
Jun 08
2022
|
David M Stack CEO and Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
21,500
+11.61%
|
-
|
|
Jun 08
2022
|
David M Stack CEO and Chairman |
SELL
Open market or private sale
|
Direct |
13,828
-2.28%
|
$829,680
$60.68 P/Share
|
|
Jun 07
2022
|
Anthony Molloy Chief Lgl & Compliance Officer |
SELL
Open market or private sale
|
Direct |
2,570
-9.16%
|
$151,630
$59.89 P/Share
|
|
Jun 07
2022
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
2,433
-9.07%
|
$150,846
$62.0 P/Share
|
|
Jun 07
2022
|
Kristen Marie Williams Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
4,649
-25.41%
|
$274,291
$59.51 P/Share
|
|
Jun 06
2022
|
Daryl Gaugler Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,106
-8.78%
|
$67,466
$61.37 P/Share
|
|
Jun 06
2022
|
Dennis Mc Loughlin Chief Customer Officer |
SELL
Open market or private sale
|
Direct |
2,140
-6.3%
|
$130,540
$61.37 P/Share
|
|
Jun 06
2022
|
Anthony Molloy Chief Lgl & Compliance Officer |
SELL
Open market or private sale
|
Direct |
2,980
-16.98%
|
$181,780
$61.37 P/Share
|
|
Jun 06
2022
|
Charles Anthony Laranjeira Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
2,813
-8.37%
|
$171,593
$61.37 P/Share
|
|
Jun 06
2022
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
2,817
-9.5%
|
$171,837
$61.37 P/Share
|
|
Jun 06
2022
|
Charles A. Reinhart Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,516
-8.17%
|
$153,476
$61.37 P/Share
|
|
Jun 06
2022
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
1,150
-7.59%
|
$70,150
$61.37 P/Share
|
|
Jun 06
2022
|
Jonathan Slonin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
362
-1.27%
|
$22,082
$61.37 P/Share
|
|
Jun 06
2022
|
Kristen Marie Williams Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
3,969
-17.82%
|
$242,109
$61.37 P/Share
|
|
Jun 06
2022
|
Roy Winston Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
17,546
-4.42%
|
$1,070,306
$61.96 P/Share
|
|
Jun 06
2022
|
Roy Winston Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+10.99%
|
$212,500
$34.38 P/Share
|
|
Jun 06
2022
|
David M Stack CEO and Chairman |
SELL
Open market or private sale
|
Direct |
11,965
-7.12%
|
$729,865
$61.37 P/Share
|
|
May 23
2022
|
Jonathan Slonin Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+6.54%
|
$104,000
$52.37 P/Share
|
|
May 09
2022
|
Mark Froimson Director |
SELL
Open market or private sale
|
Direct |
1,000
-16.93%
|
$59,000
$59.37 P/Share
|
|
Apr 28
2022
|
David M Stack CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
22,500
+11.81%
|
$225,000
$10.81 P/Share
|
|
Apr 21
2022
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
9,824
-24.89%
|
$717,152
$73.25 P/Share
|
|
Apr 21
2022
|
Max Reinhardt President, Rest of World |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+24.05%
|
$525,000
$42.54 P/Share
|
|
Apr 20
2022
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
9,764
-26.58%
|
$712,772
$73.99 P/Share
|
|
Apr 20
2022
|
Max Reinhardt President, Rest of World |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+25.39%
|
$525,000
$42.54 P/Share
|
|
Apr 19
2022
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
9,321
-27.78%
|
$671,112
$72.25 P/Share
|
|
Apr 19
2022
|
Max Reinhardt President, Rest of World |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+27.14%
|
$525,000
$42.54 P/Share
|
|
Apr 18
2022
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
8,941
-29.8%
|
$652,693
$73.55 P/Share
|
|
Apr 18
2022
|
Max Reinhardt President, Rest of World |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+29.41%
|
$525,000
$42.54 P/Share
|
|
Apr 06
2022
|
Anthony Molloy Chief Lgl & Compliance Officer |
SELL
Open market or private sale
|
Direct |
22,500
-23.0%
|
$1,732,500
$77.0 P/Share
|
|
Apr 06
2022
|
Anthony Molloy Chief Lgl & Compliance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,500
+14.83%
|
$877,500
$39.32 P/Share
|